期刊文献+

TSLP在吸烟相关慢性阻塞性肺疾病患者中表达的意义 被引量:1

Significance of TSLP expression in patients with smoking-related chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的观察炎性蛋白胸腺基质淋巴细胞生成素(TSLP)在COPD患者气道中的表达情况,结合核增殖抗原Ki-67及胶原蛋白等指标,探讨TSLP在COPD患者肺组织细胞增生及胶原蛋白沉积等纤维化改变中的相关意义。方法收集10例COPD患者手术获得的肺组织病理标本,包括吸烟COPD患者1例、非吸烟COPD患者1例、吸烟肺功能正常患者3例、非吸烟肺功能正常患者5例。采用免疫组织化学染色法分析吸烟相关COPD患者肺组织TSLP、Ki-67的表达分布,苏木素-伊红染色、Masson三色染色显示肺组织胶原蛋白等结构,分析TSLP与气道病理改变的关系。结果与非吸烟肺功能正常者比较,吸烟肺功能正常者存在呼吸性末端细支气管断裂及伴行血管平滑肌增厚、胶原蛋白沉积等改变;非吸烟COPD患者肺泡腔扩大、撕裂断开,伴行小血管动脉管腔饱胀,被牵扯变形;吸烟COPD患者增厚的呼吸性气道上皮被撕裂,存在团状聚集断裂等结构形态的变化。吸烟肺功能正常者的TSLP总光密度、胶原蛋白总光密度、Ki-67均比其他3组升高(P<0.008或0.01)。吸烟COPD者的TSLP总光密度、胶原蛋白总光密度、Ki-67阳性细胞数均比非吸烟COPD者升高(P<0.008或0.01),其TSLP总光密度高于非吸烟肺功能正常者、胶原蛋白总光密度低于非吸烟肺功能正常者(P均<0.008或0.01)。非吸烟COPD者胶原蛋白总光密度低于非吸烟肺功能正常者(P<0.01)。人肺组织中TSLP的总光密度与胶原蛋白总光密度(rs=0.547,P<0.01)及Ki-67阳性细胞数(rs=0.808,P<0.01)呈正相关,胶原蛋白光密度与Ki-67阳性细胞数也呈正相关(rs=0.620,P<0.01)。结论 TSLP可能与吸烟相关COPD发病中的肺组织细胞增生及胶原蛋白沉积有关,在吸烟相关COPD肺组织细胞增生及纤维化改变中有一定临床意义,这为COPD的临床分型及个体化治疗提供了新的靶点。 Objective To investigate the effect and mechanism of nanoscale hydroxyapatite (nHAP)upon the growth of ovarian cancer cell line SKOV3. Metliods The ovarian cancer cell tured. The 30%-, 50%- and 70%-inhibitory concentrations (IC3., IC5.and IC7.) of nHAP upon the ovariancancer cell line SKOV3 were calculated, and the dose-effect and time-effect curves were delineated. The SK-OV3 cells treated with IC5.of nHAP and those untreated with nHAP were prepared for transmission electron mi-croscopic observation ad flow cytometry detection. Results After nHAP treatment for 48 h , different concen-trations of nHAP could inhibit the growth of ovarian cancer SKOV3 cells. The IC3., IC5.cancer SKOV3 cells were calculated as 9. 46,28. 83 and 60. 80 mg/L,respectively. During the 48-different concentrations of nHAP treatment , the inhibitory rate was elevated over time and remained slow andstable after 48 h. Morphological observation and quantitative analysis demonstrated that 48-h treatment withIC50 of nHAP could induce the apoptosis of ovarian cancer SKOV3 cells with a apop12.53)%, significantly higher compared with ( (0. 88 ± 5. 48 ) % in the ccrntrol group ( P 〈 0. 05 ). Compared with the control group, the percentage of SKOV3 cells at G0/G1 phase was significantly higher, whereas the proportion of SKOV3 cells at S phase was considerably lower after treatment with IC5.of nHAP ( both P 〈 0. 05). Conclusions nHAP exerts significant effect upon suppressing the growth of ovarian cancer cell line SKOV3. The underlying mechanism is probably that nHAP afects the ovarian cancer SKOV3 cells during phase and induces the apoptosis of cancer cells.
出处 《新医学》 2017年第10期701-708,共8页 Journal of New Medicine
基金 国家自然科学基金面上项目(81370114)
关键词 慢性阻塞性肺疾病 胸腺基质淋巴细胞生成素 吸烟 Nanoscale hydroxyapatite Ovarian cancer Cell line
  • 相关文献

参考文献3

二级参考文献54

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量:11
  • 2慢性阻塞性肺疾病急性加重患者的机械通气指南(2007)[J].中国危重病急救医学,2007,19(9):513-518. 被引量:335
  • 3Luporsi E, AndrO F, Spyratos F, et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat, 2012, 132: 895-915.
  • 4Weigel MT, Dowsett M. Current and emerging biomark- ers in breast cancer: prognosis and prediction. Endocr Relat Cancer, 2010, 23: 17: R245-262.
  • 5Munzone E, Botteri E, Sciandivasci A, et al Prognostic value of Ki-67 labeling index in patients with node-nega- tive, triple-negative breast cancer. Breast Cancer Res Treat, 2012, 134: 277-282.
  • 6Yerushalmi R, Woods R, Ravdin PM, et al. Ki67 in breast cancer: prognostic and predictive potential. Lan- cet Oncol, 2010, 11 : 174-183.
  • 7Dowsett M, Nielsen TO, AHem R, et al. Assessment of Ki67 in breast cancer: recommendations from the In- ternational Ki67 in Breast Cancer workinggroup. J Natl Cancer Inst, 2011, 103 : 1656-1664.
  • 8Subik K, Lee JF, Baxter L, et al. The expression pat- terns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (Auckl), 2010, 4: 35-41.
  • 9Matsubara N, Mukai H, Fujii S, et al. Different prog- nostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes ofbreast cancer. Breast Cancer Res Treat, 2013, 137: 203-212.
  • 10Tanei T, Shimomura A, Shimazu K, et al. Prognostic significance of Ki67 index after neoadjuvant chemothera- py in breast cancer. Eur J Surg Oncol, 2011, 3: 155- 161.

共引文献163

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部